Probiotic Supplementation improves Clinical Outcomes and Quality of Life indicators in Patients with Plaque Psoriasis: A Randomized Double-Blind Clinical Trial

Probiotic Supplementation improves Clinical Outcomes and Quality of Life indicators in Patients with Plaque Psoriasis: A Randomized Double-Blind Clinical Trial


چاپ صفحه
پژوهان
صفحه نخست سامانه
چکیده مقاله
چکیده مقاله
نویسندگان
نویسندگان
دانلود مقاله
دانلود مقاله
دانشگاه علوم پزشکی تبریز
دانشگاه علوم پزشکی تبریز

نویسندگان: محمد علی زاده , سمیه سعیدی , حمیدرضا رزمی

کلمات کلیدی: Probiotic; Psoriasis; Oxidative stress; Quality of life; Clinical outcome

نشریه: 0 , 2021 , 46 , 2021

اطلاعات کلی مقاله
hide/show

نویسنده ثبت کننده مقاله حمیدرضا رزمی
مرحله جاری مقاله تایید نهایی
دانشکده/مرکز مربوطه کمیته تحقیقات دانشجویی
کد مقاله 77227
عنوان فارسی مقاله Probiotic Supplementation improves Clinical Outcomes and Quality of Life indicators in Patients with Plaque Psoriasis: A Randomized Double-Blind Clinical Trial
عنوان لاتین مقاله Probiotic Supplementation improves Clinical Outcomes and Quality of Life indicators in Patients with Plaque Psoriasis: A Randomized Double-Blind Clinical Trial
ناشر 6
آیا مقاله از طرح تحقیقاتی و یا منتورشیپ استخراج شده است؟ بلی
عنوان نشریه (خارج از لیست فوق) Clinical Nutrition ESPEN
نوع مقاله Original Article
نحوه ایندکس شدن مقاله ایندکس شده سطح یک – ISI - Web of Science
آدرس لینک مقاله/ همایش در شبکه اینترنت

خلاصه مقاله
hide/show

Background & aims The impact of probiotics on psoriasis, a systemic inflammatory disease, remains obscure, thus we decided to evaluate quality of life (QOL), oxidative stress, inflammatory markers and clinical outcome in psoriasis patients. Methods Fifty patients with plaque psoriasis randomized into two groups, group 1 received probiotic drink with Lactobacillus strains for 8 weeks while group 2 haven't received any probiotic supplements at this period. The Dermatology Life Quality Index (DLQI) and Beck's questionnaire (BDI) were used to investigate the quality of life and depression, respectively. The effects of supplementation on malondialdehyde (MDA), hs-CRP, IL-6, total antioxidant capacity (1) and psoriasis area and severity index (PASI), psoriasis symptom scale (PSS) were measured at the beginning of the study and after week 8th. Results Total BDI scores significantly improved in the probiotic group in comparison with the placebo group (−6.15 ± 2.10 vs. 1.39 ± 1.80, P = 0.017) and DLQI (−9.50 ± 4.1 vs. 0.12 ± 0.6, P = 0.045) as well. Group 1 had a considerable reduction in PASI and PSS scores compared to the placebo group (−5.26 ± 3.75 vs. 0.48 ± 1.37, P = 0.049) and (−4.85 ± 3.10 vs. 0.43 ± 0.80, P = 0.047), respectively. In addition, the intervention group have shown increase in TAC levels (45.99 ± 23.33 vs −13.54 ± 30.7 mmol/L, P = 0.030), and decrease in hs-CRP levels (−1.55 ± 0.85 vs. −0.49 + 0.27 mg/L, P = 0.015), IL-6 levels (−4.04 ± 1.30 vs. −1.50 + 0.38 mg/L, P = 0.050) and MDA levels (−71.08 ± 35.73 vs. −9.8 + 15.6 nmol/mL, P = 0.013) compared to the placebo group. Conclusions Probiotics improve patients' quality of life and inflammatory biomarkers in psoriatic patients. Further studies are mandatory to propose probiotics as routinely prescribed therapy in inflammatory dermatoses.

نویسندگان
hide/show

نویسنده نفر چندم مقاله
محمد علی زادهپنجم
سمیه سعیدیسوم
حمیدرضا رزمیچهارم

لینک دانلود مقاله
hide/show

نام فایل تاریخ درج فایل اندازه فایل دانلود
main.pdf1401/01/24581978دانلود